Filing Details
RAPID MICRO BIOSYSTEMS, INC. (NASDAQ:RPID) filed its quarterly report (Form 10-Q) with the Securities and Exchange Commission on August 07, 2026.
The Healthcare company reported Q0 revenue of .
10q filedNASDAQ:RPID
RAPID MICRO BIOSYSTEMS, INC. (RPID) Files Quarterly Report for Q0
RAPID MICRO BIOSYSTEMS, INC. (NASDAQ:RPID) filed its quarterly report (Form 10-Q) with the Securities and Exchange Commission on August 07, 2026.
At publication ·
What changed
RAPID MICRO BIOSYSTEMS, INC. (NASDAQ:RPID) · 10q filed
- Form
- 10-Q
At a glance
Key takeaways
- Rapid Micro Biosystems (NASDAQ: RPID) filed its quarterly report (Form 10-Q) on August 7, 2026, providing unaudited financial statements and management commentary on recent performance.
- The company's stock trades at $1.73 with a market capitalization of $165.0 million as of the filing date.
- The 10-Q filing contains timely information about emerging trends, updated risk factors, and changes in business conditions since the last annual report.
Market Context
RAPID MICRO BIOSYSTEMS, INC.'s stock currently trades at $1.73 with a market capitalization of $165.0M.
The 10-Q provides RAPID MICRO BIOSYSTEMS, INC.'s quarterly financial update, including unaudited financial statements and management commentary on recent performance. While less detailed than the annual 10-K, the 10-Q often contains timely information about emerging trends, updated risk factors, and changes in business conditions since the last filing.
All SEC filings for RAPID MICRO BIOSYSTEMS, INC. are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View RPID Stock Page
Frequently Asked Questions
Where can I read RPID's SEC filings?
Browse all filings on our RPID SEC filings page.
What types of SEC filings does RAPID MICRO BIOSYSTEMS, INC. file?
Public companies like RAPID MICRO BIOSYSTEMS, INC. file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.